Literature DB >> 8113679

Interleukin 2 induces the expression of CD45RO and the memory phenotype by CD45RA+ peripheral blood lymphocytes.

M D Roth1.   

Abstract

The CD45RA and CD45RO isoforms of the leukocyte common antigen identify functionally distinct "naive" and "memory" T cell subsets. While antigenic and mitogenic stimuli are known to initiate transition from the naive to memory state, little is known about the role of cytokines in this process. This report demonstrates that in vitro exposure of purified CD45RA+/CD45RO- peripheral blood lymphocytes (PBL) to interleukin 2 (IL-2) promotes their conversion to the CD45RA-/CD45RO+ phenotype. Conversion to CD45RO occurs for both the CD3+ and CD3-/CD56+ lymphocyte subsets, but occurs more rapidly, and at lower IL-2 concentrations, in the CD3-/CD56+ population. Expression of CD45RO was observed only in response to IL-2 and was not observed during long-term culture in IL-4, IL-6, or IL-7. We also examined the effect of IL-2 on the expression of adhesion molecules by T cells. The expression of CD2, CD11a, and CDw29 increased, and expression of Leu-8 (LAM-1) decreased, on cultured CD45RA+/CD45RO- cells after they converted to expression of CD45RO. In contrast, lymphocytes that remained CD45RA+/CD45RO- after 10 d in culture exhibited no change from their baseline adhesion molecule profile. Finally, to test the role of endogenous IL-2 during T cell activation we stimulated CD45RA+/CD45RO- PBL with immobilized anti-CD3 in the presence of neutralizing anti-IL-2 antibody and/or cyclosporin A. Both agents significantly reduced the expression of CD45RO and the effect of cyclosporin A was reversed by exogenous IL-2. We conclude that IL-2 promotes CD45RA+ cells to express the memory phenotype and is a mediator of CD45RO expression after stimulation of the T cell receptor/CD3 complex.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113679      PMCID: PMC2191429          DOI: 10.1084/jem.179.3.857

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  35 in total

Review 1.  The leukocyte common antigen family.

Authors:  M L Thomas
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  A second signal for T cell mitogenesis provided by monoclonal antibodies CD45 (T200).

Authors:  J Martorell; R Vilella; L Borche; I Rojo; J Vives
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

3.  Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.

Authors:  R S Mittler; R S Greenfield; B Z Schacter; N F Richard; M K Hoffmann
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

4.  Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells.

Authors:  A N Akbar; L Terry; A Timms; P C Beverley; G Janossy
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

5.  Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.

Authors:  M J Robertson; M A Caligiuri; T J Manley; H Levine; J Ritz
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

6.  Age-related changes in human lymphocyte subsets: progressive reduction of the CD4 CD45R (suppressor inducer) population.

Authors:  P De Paoli; S Battistin; G F Santini
Journal:  Clin Immunol Immunopathol       Date:  1988-09

7.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

Authors:  M E Sanders; M W Makgoba; S O Sharrow; D Stephany; T A Springer; H A Young; S Shaw
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

8.  Production of lymphokine mRNA by CD45R+ and CD45R- helper T cells from human peripheral blood and by human CD4+ T cell clones.

Authors:  M Salmon; G D Kitas; P A Bacon
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

9.  Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies.

Authors:  M Dohlsten; G Hedlund; H O Sjögren; R Carlsson
Journal:  Eur J Immunol       Date:  1988-08       Impact factor: 5.532

10.  Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens.

Authors:  M Streuli; L R Hall; Y Saga; S F Schlossman; H Saito
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  12 in total

1.  IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.

Authors:  V Dardalhon; S Jaleco; S Kinet; B Herpers; M Steinberg; C Ferrand; D Froger; C Leveau; P Tiberghien; P Charneau; N Noraz; N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

Review 2.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

3.  In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients.

Authors:  Irini Sereti; Hiromi Imamichi; Ven Natarajan; Tomozumi Imamichi; Meena S Ramchandani; Yunden Badralmaa; Steve C Berg; Julia A Metcalf; Barbara K Hahn; Jean M Shen; April Powers; Richard T Davey; Joseph A Kovacs; Ethan M Shevach; H Clifford Lane
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

4.  T-cell-mediated immunity to lymphocytic choriomeningitis virus in beta2-integrin (CD18)- and ICAM-1 (CD54)-deficient mice.

Authors:  J P Christensen; O Marker; A R Thomsen
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Expansion of cytotoxic CD8+ CD28- T cells in healthy ageing people, including centenarians.

Authors:  F F Fagnoni; R Vescovini; M Mazzola; G Bologna; E Nigro; G Lavagetto; C Franceschi; M Passeri; P Sansoni
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

6.  Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

Authors:  P De Paoli; S Zanussi; C Simonelli; M T Bortolin; M D'Andrea; C Crepaldi; R Talamini; M Comar; M Giacca; U Tirelli
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

7.  CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells.

Authors:  C E Demeure; D G Byun; L P Yang; N Vezzio; G Delespesse
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

8.  Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Authors:  S Jyothi Prasanna; Divya Gopalakrishnan; Shilpa Rani Shankar; Anoop Babu Vasandan
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

9.  Costimulation of naive CD8(+) lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection.

Authors:  S G Kitchen; Y D Korin; M D Roth; A Landay; J A Zack
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  An improved ontological representation of dendritic cells as a paradigm for all cell types.

Authors:  Anna Maria Masci; Cecilia N Arighi; Alexander D Diehl; Anne E Lieberman; Chris Mungall; Richard H Scheuermann; Barry Smith; Lindsay G Cowell
Journal:  BMC Bioinformatics       Date:  2009-02-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.